Trade LNAI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Lunai Bioworks Inc. (LNAI) is trading at US$2.40, up 1.91% today as of Aug 28, 12:41 EDT. The company has a market capitalisation of US$9.77M. Over the past 52 weeks, LNAI has traded between US$1.13 and US$13.28. On Syfe you can trade LNAI with $0 commission and add it to your watchlist.
| Previous close | US$2.35 |
|---|---|
| Market cap | US$9.77M |
| 52-week range | US$1.13 – US$13.28 |
| Volume | 39.84K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lunai Bioworks Inc.
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
Year: 2014
Top Premarket Gainers
Jun 17, 11:08 AM · MT Newswires
Lunai Bioworks Inc. (LNAI) stock is trading at US$2.40, +1.91% from the previous close of US$2.35.
The market cap for Lunai Bioworks Inc. (LNAI) stock is approximately US$9.77M.
The 52-week high for Lunai Bioworks Inc. (LNAI) stock is US$13.28.
The 52-week low for Lunai Bioworks Inc. (LNAI) stock is US$1.13.
Lunai Bioworks Inc. (LNAI) does not currently pay a dividend.
Stay on top of LNAI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
